Research published today in the journal Circulation: Cardiovascular Quality and Outcomes found that Medicare Part D beneficiaries with cardiovascular conditions who had no financial assistance during the "donut hole" coverage gap were 57 percent more likely to discontinue their cardiovascular medications than those beneficiaries who had consistent drug coverage.
For the study, researchers from Harvard University, Brigham and Women's Hospital and CVS Caremark examined prescription drug usage for cardiovascular conditions among more than 122,000 Medicare beneficiaries who reached the Medicare Part D donut hole in 2006 or 2007. The donut hole is known as the coverage gap under Medicare Part D in which Medicare beneficiaries are 100-percent responsible for medication costs until they have spent more than $4,550.
The researchers concluded that cost-sharing mechanisms like the coverage gap prompted beneficiaries to discontinue their medications more frequently than beneficiaries who had stable drug coverage. In addition, the results showed that beneficiaries were no more likely to switch to generic medications during the donut hole.
While the study found no increase in short-term negative health issues during the coverage gap, the long-term health impact of non-adherence to cardiovascular drugs during the coverage gap is unclear.
For the study, researchers from Harvard University, Brigham and Women's Hospital and CVS Caremark examined prescription drug usage for cardiovascular conditions among more than 122,000 Medicare beneficiaries who reached the Medicare Part D donut hole in 2006 or 2007. The donut hole is known as the coverage gap under Medicare Part D in which Medicare beneficiaries are 100-percent responsible for medication costs until they have spent more than $4,550.
The researchers concluded that cost-sharing mechanisms like the coverage gap prompted beneficiaries to discontinue their medications more frequently than beneficiaries who had stable drug coverage. In addition, the results showed that beneficiaries were no more likely to switch to generic medications during the donut hole.
While the study found no increase in short-term negative health issues during the coverage gap, the long-term health impact of non-adherence to cardiovascular drugs during the coverage gap is unclear.
Related Articles on Medication Safety:
est Calcasieu Cameron Hospital Uses Bar Code Wristbands to Prevent Medication Errors
Paul Levy: How to Get Better at Harming People Less
15 Greatest Opportunities for Hospital Savings